205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.04%
Revenue growth above 1.5x ON's 0.01%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
0.29%
Gross profit growth under 50% of ON's 0.62%. Michael Burry would be concerned about a severe competitive disadvantage.
0.32%
EBIT growth below 50% of ON's 11.87%. Michael Burry would suspect deeper competitive or cost structure issues.
-0.96%
Negative operating income growth while ON is at 11.87%. Joel Greenblatt would press for urgent turnaround measures.
297.09%
Positive net income growth while ON is negative. John Neff might see a big relative performance advantage.
294.29%
Positive EPS growth while ON is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
297.06%
Positive diluted EPS growth while ON is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.20%
Share reduction while ON is at 0.38%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Reduced diluted shares while ON is at 2.52%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.20%
Dividend growth of 0.20% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-42.35%
Negative OCF growth while ON is at 0.98%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-45.64%
Negative FCF growth while ON is at 171.53%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
56.33%
10Y revenue/share CAGR under 50% of ON's 135.21%. Michael Burry would suspect a lasting competitive disadvantage.
47.90%
5Y revenue/share CAGR under 50% of ON's 119.96%. Michael Burry would suspect a significant competitive gap or product weakness.
27.80%
3Y revenue/share CAGR under 50% of ON's 60.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
134.19%
10Y OCF/share CAGR above 1.5x ON's 19.18%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
247.85%
5Y OCF/share CAGR 1.25-1.5x ON's 180.58%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
94.00%
3Y OCF/share CAGR at 50-75% of ON's 174.76%. Martin Whitman would suspect weaker recent execution or product competitiveness.
178.55%
Below 50% of ON's 383.47%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
324.95%
5Y net income/share CAGR at 50-75% of ON's 551.93%. Martin Whitman might see a shortfall in operational efficiency or brand power.
121.24%
3Y net income/share CAGR 75-90% of ON's 156.63%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
45.75%
Below 50% of ON's 115.56%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
9.43%
Below 50% of ON's 123.38%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
9.04%
Below 50% of ON's 84.74%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.16%
Dividend/share CAGR of 520.16% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
196.58%
Dividend/share CAGR of 196.58% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.35%
3Y dividend/share CAGR of 82.35% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
13.77%
Our AR growth while ON is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.83%
Inventory growth well above ON's 6.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.77%
Negative asset growth while ON invests at 0.95%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.16%
50-75% of ON's 4.98%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
0.02%
We have some new debt while ON reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.26%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
5.87%
We expand SG&A while ON cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.